Our independence in commissioning research to deliver the Gambling Commission’s National Strategy to Reduce Gambling Harms is ensured by the Research Commissioning and Governance Procedure agreed with the Gambling Commission and updated in September 2018. This sets out how research priorities are identified, and research projects commissioned, through the tripartite agreement between the Gambling Commission, the Advisory Board for Safer Gambling and GambleAware.
We follow Research Council policy regarding research ethics, encouraging and funding open access publication in academic journals and data reuse.
GambleAware has been approved by National Institute for Health Research (NIHR) as an NIHR non-commercial partner. As such, appropriate research studies funded by GambleAware are eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to access NHS support via the NIHR CRN, subject to meeting standard study eligibility criteria including that the research has clear value to the NHS and involves NHS patients, staff, premises, facilities, or resources.